Targeting Mitochondrial Dysfunction with Mdivi-1 Confers Therapeutic Protection in a Mouse Model of Mustard Keratopathy

The human eye is a delicate organ, constantly exposed to the outside world. When it encounters a chemical burn, the damage can be swift and devastating. One particularly dangerous class of chemicals, known as mustard agents, were originally developed as weapons of war but remain a threat to public health today. If these substances touch the cornea, the clear front window of the eye, they trigger a cascade of injury that often leads to permanent blindness. For decades, doctors have treated these injuries by trying to calm the resulting inflammation, much like putting a bandage on a deep wound. However, this approach often fails to stop the long-term damage or help the eye heal properly, leaving patients with chronic pain and vision loss. The core problem has been that while scientists knew the eye was being destroyed, they did not fully understand the specific machinery inside the cells that was breaking down.

A new study from researchers at Tufts University and other institutions has finally identified that missing piece of the puzzle. They discovered that when mustard gas touches the cornea, it attacks the tiny power plants inside the eye's surface cells, known as mitochondria. These power plants are essential for keeping cells alive and functioning. Under normal conditions, they form a connected, healthy network. But when mustard gas strikes, these power plants are forced to break apart into tiny, useless fragments. This fragmentation causes the cells to run out of energy, fill with toxic waste, and eventually die. The researchers found that by using a specific drug to stop this breaking-apart process, they could keep the power plants intact, allowing the cells to survive and the eye to heal. This discovery suggests a new way to treat chemical burns that targets the root cause of the damage rather than just the symptoms.

The team began their investigation by looking at human corneal cells in a laboratory dish. They exposed these cells to nitrogen mustard, a common type of vesicant agent, to mimic a chemical burn. Within just two hours, the cells showed clear signs of distress. The researchers used special dyes to watch what happened inside the cells, and they saw that the mitochondria, which usually look like long, branching threads, suddenly snapped into tiny, scattered dots. This process is called fission, and in this case, it was happening far too quickly and too aggressively. The cells also lost their internal electrical charge, a sign that their power plants were failing, and they began to produce dangerous levels of toxic oxygen byproducts. The cells were essentially drowning in their own waste and running out of energy.

To test if they could stop this destruction, the scientists introduced a drug called Mdivi-1. This drug is designed to block the specific protein that acts as the scissors cutting the mitochondria apart. When the researchers added this drug to the cells before exposing them to the mustard gas, the results were striking. The mitochondria stayed connected and healthy, looking much like they did in untreated cells. The cells maintained their energy levels, produced far fewer toxic byproducts, and survived the chemical attack. The researchers also tested a second, more selective drug that targets the same protein, and it produced the same protective effect. This confirmed that the damage was indeed caused by the mitochondria breaking apart, and that stopping this breakage was the key to saving the cells.

The study went beyond the lab dish to see if these findings would hold up in a living animal. The researchers used mice that had been genetically modified to carry a special glowing tag on their mitochondria. This tag allowed them to see the health of the power plants in real time: healthy mitochondria glowed green, while damaged, aging ones glowed red. When they applied nitrogen mustard to the mice's eyes, the corneas quickly turned red, showing that the mitochondria were being damaged and oxidized. The injury was severe, causing inflammation and tissue damage that persisted for weeks. However, when the researchers treated the injured eyes with Mdivi-1 eye drops, the outcome changed dramatically. The treated eyes showed much less red glow, meaning the mitochondria remained healthy. The corneas healed faster, the tissue structure was preserved, and the eye surface remained smooth and intact.

One of the most important aspects of this work is what it rules out. For a long time, scientists assumed that the damage from mustard gas was primarily caused by the chemical directly attacking DNA or depleting the body's natural antioxidants. While those things happen, this study shows that the real driver of the cell death is the physical breaking of the mitochondria. The researchers tested whether the drug Mdivi-1 worked by acting as a direct antioxidant, like a sponge soaking up toxic chemicals. They found that it did not. The drug had almost no ability to neutralize toxins on its own. Instead, its power came entirely from keeping the mitochondria whole. By preventing the organelles from shattering, the cells were able to keep their own natural defenses working and clear out the damage themselves. This distinction is crucial because it means the treatment works by fixing the broken machinery, not just by mopping up the mess.

The researchers also looked at how the eye repaired itself over time. In the untreated mice, the damage lingered for weeks, with the cornea remaining inflamed and the mitochondria staying in a damaged, red state. In the mice treated with Mdivi-1, the cornea healed much more quickly. By day 28, the treated eyes had recovered about 92 percent of their surface integrity, compared to only 21 percent in the untreated eyes. The treated eyes also showed a return of healthy green mitochondria, indicating that the cells were not just surviving but actively renewing themselves. The drug helped the eye clear out the old, damaged power plants and replace them with new, healthy ones, a process that is essential for long-term healing.

This work provides a strong foundation for a new type of medical treatment for chemical burns. Currently, the standard care for mustard gas injuries involves steroids to reduce inflammation. While these drugs help with swelling, they do not stop the underlying cellular destruction and can sometimes delay healing. The new approach targets the root cause: the mitochondrial fragmentation. By keeping the power plants intact, the treatment allows the eye's natural repair mechanisms to work. The researchers noted that their drug performed as well as, and in some cases slightly better than, the standard steroid treatment in the mouse model. Because the drug works on a mechanism that is fundamental to how cells handle stress, it could potentially be useful for other types of eye injuries as well.

The study also highlights the importance of understanding the specific steps of cell death. The researchers showed that the damage happens in a specific order: the chemical triggers the mitochondria to break, which leads to energy failure and toxic buildup, which finally causes the cell to die. By intervening at the very first step—the breaking of the mitochondria—they were able to stop the entire chain reaction. This is a significant shift from previous strategies that tried to treat the symptoms after the damage had already occurred. The success of the treatment in both cell cultures and living mice suggests that this approach is robust and could be translated to human patients.

While the results are promising, the researchers are careful to note that more work is needed. The studies were conducted in mice and in a dish, and human eyes may respond differently. The team also plans to investigate how long the protection lasts and whether the treatment can prevent the chronic problems that often follow chemical burns, such as scarring and nerve damage. They also want to understand exactly how the mustard gas triggers the mitochondria to break in the first place. Despite these questions, the study offers a clear path forward. It identifies a specific, actionable target for therapy and demonstrates that protecting the cell's power plants can save the eye from a devastating injury. For patients suffering from mustard keratopathy, this research offers a genuine hope for a treatment that does more than just manage pain—it could restore the ability to see.